The Role of Adenosine A2A Receptor Signaling in Bronchiolitis Obliterans

Annals of Thoracic Surgery

Volumn 88, Issue 4, 2009, Pages 1071-1078

  Lau, Christine L ^a   Zhao, Yunge ^a   Kron, Irving L ^a   Stoler, Mark H ^a   Laubach, Victor E ^a   Ailawadi, Gorav ^a   Linden, Joel ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ATL 313; COLLAGEN; EOSIN; HEMATOXYLIN; UNCLASSIFIED DRUG; CD3 ANTIGEN;

AIRWAY OBSTRUCTION; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DISEASE MODEL; GRAFT REJECTION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRACHEA; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELLULAR IMMUNITY; DISEASE COURSE; IMMUNOLOGY; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MOUSE MUTANT; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; T LYMPHOCYTE; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD3; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; IMMUNITY, CELLULAR; IMMUNOHISTOCHEMISTRY; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRACHEA;

EID: 70249122395     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.06.032     Document Type: Article

References (30)

1. Chan A., and Allen R. Bronchiolitis obliterans: an update. Curr Opin Pulm Med 10 (2004) 133-141
2. Sharples L.D., McNeil K., Stewart S., and Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21 (2002) 271-281
3. McKane B.W., Trulock E.P., Patterson G.A., and Mohanakumar T. Lung transplantation and bronchiolitis obliterans: an evolution in understanding. Immunol Res 24 (2001) 177-190
4. Jaramillo A., Naziruddin B., Zhang L., et al. Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome. Transplantation 71 (2001) 966-976
5. Davis Jr. R.D., Lau C.L., Eubanks S., et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 125 (2003) 533-542
6. Lau C.L., Palmer S.M., Howell D.N., et al. Laparoscopic antireflux surgery in the lung transplant population. Surg Endoscopy 16 (2002) 1674-1678
7. Day Y.-J., Li Y., Rieger J.M., Ramos S.I., Okusa M.D., and Linden J. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunology 174 (2005) 5040-5046
8. Reutershan J., Cagnina R.E., Chang D., Linden J., and Ley K. Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunology 179 (2007) 1254-1263
9. Gazoni L.M., Laubach V.E., Mulloy D.P., et al. Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion. J Thorac Cardiovasc Surg 135 (2008) 156-165
10. Lappas C.M., Day Y.-J., Marshall M.A., Engelhard V.H., and Linden J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Experiment Med 203 (2006) 2639-2648
11. Li L., Huang L., Sung S.J., et al. NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury. J Immunology 178 (2007) 5899-5911
12. Yang Z., Day Y.-J., Toufektsian M.-C., et al. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation 114 (2006) 2056-2064
13. Peirce S.M., Skalak T.C., Rieger J.M., Macdonald T.L., and Linden J. Selective A(2A) adenosine receptor activation reduces skin pressure ulcer formation and inflammation. Am J Physiol Heart Circ Physiol 281 (2001) H67-H74
14. Ohta A., and Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414 (2001) 916-920
15. Lappas C.M., Rieger J.M., and Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunology 174 (2005) 1073-1080
16. Sevigny C.P., Li L., Awad A.S., et al. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J Immunology 178 (2007) 4240-4249
17. Naganuma M., Wiznerowicz E.B., Lappas C.M., Linden J., Worthington M.T., and Ernst P.B. Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunology 177 (2006) 2765-2769
18. Erdmann A.A., Gao Z.G., Jung U., et al. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2 driven expansion in vivo. Blood 105 (2005) 4707-4714
19. Ohta A., Gorelik E., Prasad S.J., et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 103 (2006) 13132-13137
20. Deaglio S., Dwyer K.M., Gao W., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Experiment Med 204 (2007) 1257-1265
21. Zarek P.E., Huang C.-T., Lutz E.R., et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111 (2008) 251-259
22. Belperio J.A., Keane M.P., Burdick M.D., et al. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 108 (2001) 547-556
23. Belperio J.A., Keane M.P., Burdick M.D., et al. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunology 169 (2002) 1037-1049
24. McDyer J.F. Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac Soc 4 (2007) 37-43
25. Fredholm B.B., Zhang Y., and van der Ploeg I. Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn Schmiedebergs Arch Pharmacol 354 (1996) 262-267
26. Link A.A., Kino T., Worth J.A., et al. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunology 164 (2000) 436-442
27. Daud S.A., Yusen R.D., Meyers B.F., et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 175 (2007) 507-513
28. Fiser S.M., Tribble C.G., Long S.M., et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome. Ann Thorac Surg 73 (2002) 1041-1047 discussion 1047-8
29. Okazaki M., Krupnick A.S., Kornfeld C.G., et al. A mouse model of orthotopic vascularized aerated lung transplantation. Am J Transplant 7 (2007) 1672-1679
30. Panoskaltsis-Mortari A., Tram K.V., Price A.P., Wendt C.H., and Blazar B.R. A new murine model for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med 176 (2007) 713-723